SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Capasso Planning 13F Filing

Capasso Planning Partners LLC files 13F form with SEC, disclosing holdings. Minor update on investment portfolio.

SquawkNews Desk

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories

DaVita Repurchased 382,563 Shares From Berkshire Hathaway SEC filings show Berkshire Hathaway still owned about 28.3 million DaVita shares following the repurchase. M impact | EQUITY | Oct 29, 2026, 09:45 PM UTC Alphabet Shares Fall Nearly 13% as New York Stocks Decline New York stocks closed lower as technology shares retreated, with Alphabet falling nearly 13%. H impact | EQUITY | Oct 29, 2026, 09:41 PM UTC Saba Capital Management Reports $10,816.56 Acquisition of BNY Mellon Municipal Bond Fund Shares Saba Capital Management reported acquiring $10,816.56 in common shares of BNY Mellon Strategic Municipal Bond Fund. M impact | EQUITY | Oct 29, 2026, 09:41 PM UTC Veralto Q3 Adjusted Earnings and Revenue Rise, 2026 Outlook Lifted Veralto reported higher Q3 adjusted earnings and revenue and lifted its 2026 outlook. M impact | EQUITY | Oct 29, 2026, 09:36 PM UTC Amazon CEO Sees Compute Capacity Demand Visibility Through 2029 Amazon’s CEO said the company has very good visibility into compute capacity demand in 2027 and 2028, and some of 2029. M impact | EQUITY | Oct 29, 2026, 09:35 PM UTC Argus Research Upgrades Biogen to Buy, Sets $280 Price Target Argus Research upgraded Biogen to Buy from Hold and set a $280 price target. The target implies 12.2% upside from the Oct. 29 close of $249.65. M impact | EQUITY | Oct 29, 2026, 09:34 PM UTC